CEP1612
CEP1612 is a dipeptidyl proteasome inhibitor with the IC50 of 60 nM. CEP1612 induces p21(WAF1)and p27(KIP1) expression and cell apoptosis. CEP1612 shows anticancer activity in vivo.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 189036-01-9
- 화학식: C35H53N7O7
- 분자량:683.84
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
Chemical Information
-
CAS No. 189036-01-9
-
분자량 683.84
-
화학식 C35H53N7O7
-
SMILES
O=C1C2=CC=CC=C2C(N1CCCCCCCCC(C3CCCC3)C(N[C@@H](CCCNC(NN(=O)=O)=N)C(N[C@H](C=O)CC(C)C)=O)=O)=O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
[1]. An B, et al. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death Differ. 1998;5(12):1062-1075. [Content Brief]
[2]. Sun J, et al. CEP1612, a dipeptidyl proteasome inhibitor, induces p21WAF1 and p27KIP1 expression and apoptosis and inhibits the growth of the human lung adenocarcinoma A-549 in nude mice. Cancer Res. 2001;61(4):1280-1284. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)